CoChat

PSMC5 insufficiency and P320R mutation impair proteasome function

Open access

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index; 21 of the 30 sources its claims cite were checked for support.

Abstract

The ubiquitin-proteasome system mediates the degradation of a wide variety of proteins. Proteasome dysfunction is associated with neurodegenerative diseases and neurodevelopmental disorders in humans. Here we identified mutations in PSMC5, an AAA ATPase subunit of the proteasome 19S regulatory particle, in individuals with neurodevelopmental disorders, which were initially considered as variants of unknown significance. We have now found heterozygotes with the following mutations: P320R (6 individuals), R325W, Q160A, and one nonsense mutation at Q69. We focused on understanding the functional consequence of PSMC5 insufficiency and the P320R mutation in cells and found that both impair proteasome function and activate apoptosis. Interestingly, the P320R mutation impairs proteasome function by weakening the association between the 19S regulatory particle and the 20S core particle. Our study supports that proteasome dysfunction is the pathogenic cause of neurodevelopmental disorders in individuals carrying PSMC5 variants.

Overview

CoChat Summary

TL;DR

This study links heterozygous PSMC5 variants to neurodevelopmental disorders and shows that PSMC5 insufficiency or the P320R mutation impairs proteasome function and activates apoptosis. The P320R mutation specifically weakens the association between the 19S regulatory particle and the 20S core particle, reducing 26S/30S proteasomes.

Key findings

  • Heterozygous PSMC5 variants were identified in individuals with neurodevelopmental delay and intellectual disability: P320R in 6 individuals, plus R325W, Q160A, and a nonsense Q69Ter variant; all were de novo except Case 6, where inheritance was uncertain.
  • PSMC5 knockdown in HeLa and SH-SY5Y cells increased K48-ubiquitinated proteins, cleaved caspase-3, and cell death; cell death was rescued by the apoptosis inhibitor Z-VAD (50 μM) but not by ferroptosis, necroptosis, or pyroptosis inhibitors.
  • Knockdown of 19S subunits PSMC5, PSMC3, PSMD2, or PSMD12 diminished chymotrypsin-like activity of 30S and 26S proteasomes but enhanced 20S proteasome activity, with decreased 30S/26S pools and increased 20S pools.
  • In engineered BE(2)-M17 cells, heterozygous and homozygous PSMC5 P320R increased cell death, K48-ubiquitinated proteins, and caspase-3 cleavage, impaired Ub-G76V-GFP degradation, and reduced co-immunoprecipitation of 20S core subunits with the 19S particle while leaving 19S subunits associated.

Methods

  • Clinical cases were patients referred for global developmental delay and intellectual disability; PSMC5 variants were identified by trio whole-genome sequencing, with 7 cases described and additional cases noted in DECIPHER.
  • Cell models included HeLa, SH-SY5Y, and engineered BE(2)-M17 cells carrying heterozygous or homozygous PSMC5 P320R; PSMC5 and other 19S subunits were depleted by siRNA.
  • Assays included LDH and CellTox Green cytotoxicity, Western blotting, immunoprecipitation, in-gel proteasome chymotrypsin-like activity using Suc-LLVY-AMC, and FACS-based Ub-G76V-GFP degradation; statistics used mean ± SD with two-tailed paired t-tests or one-way ANOVA with Dunnett’s test.

Limitations

  • Stated: the authors note that animal models would likely be necessary to understand the exact mechanism by which PSMC5 variants cause clinical features, and that future work should examine developmental pathways and possible proteotoxicity.
  • Stated: because P320R sits near the PSMD10/gankyrin binding region, the authors cannot rule out an assembly defect in addition to destabilizing effects; they also suggest compensatory programmes such as autophagy, integrated stress response, and Nrf1 targets may contribute.
  • Evident: the functional work relies on cancer and neuroblastoma cell lines rather than patient neurons or tissues, the clinical series is small and clinically heterogeneous, and Case 6 lacks evidence of de novo versus inherited origin.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddae085

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Graphical Abstract
Graphical Abstract CC BY · PubMed Central
Figure 1 PSMC5 knockdown results in accumulation of K48-ubiquitinated proteins and apoptotic cell death in HeLa cells. (A) Western blotting of PSMC5 levels after PSMC5 siRNA knockdown using SMARTpool or four deconvoluted oligos. GAPDH served as protein loading control. (B) LDH cytotoxicity assay to measure cell death caused by PSMC5 knockdown. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) Western blotting and quantification of PSMC5, K48-ubiquitinated proteins, and cleaved caspase-3 levels in PSMC5-knockdown cells. GAPDH served as protein loading control. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (D) LDH cytotoxicity assay to measure the inhibition effect of ferroptosis inhibitors (ferrostatin-1, liproxstatin-1), necroptosis inhibitors (necrostatin-1, necrosulfonamide), pyroptosis inhibitor (Z-YVAD), and apoptosis inhibitor (Z-VAD) on cell death caused by PSMC5 knockdown. Cell death of drug treatment groups was normalized to DMSO treated wild-type, PSMC5 knockdown with oligo1 or oligo2, respectively. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using one-way ANOVA with post-hoc Dunnett’s multiple comparison test. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; NS, not significant.
Figure 1 PSMC5 knockdown results in accumulation of K48-ubiquitinated proteins and apoptotic cell death in HeLa cells. (A) Western blotting of PSMC5 levels after PSMC5 siRNA knockdown using SMARTpool or four deconvoluted oligos. GAPDH served as protein loading control. (B) LDH cytotoxicity assay to measure cell death caused by PSMC5 knockdown. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) Western blotting and quantification of PSMC5, K48-ubiquitinated proteins, and cleaved caspase-3 levels in PSMC5-knockdown cells. GAPDH served as protein loading control. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (D) LDH cytotoxicity assay to measure the inhibition effect of ferroptosis inhibitors (ferrostatin-1, liproxstatin-1), necroptosis inhibitors (necrostatin-1, necrosulfonamide), pyroptosis inhibitor (Z-YVAD), and apoptosis inhibitor (Z-VAD) on cell death caused by PSMC5 knockdown. Cell death of drug treatment groups was normalized to DMSO treated wild-type, PSMC5 knockdown with oligo1 or oligo2, respectively. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using one-way ANOVA with post-hoc Dunnett’s multiple comparison test. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; NS, not significant.CC BY · PubMed Central
Figure 2 Knockdowns of the 19S RP subunits of the 26S proteasome impairs proteasome function and leads to apoptosis in HeLa cells. (A) LDH cytotoxicity assay to measure cell death caused by PSMC5, PSMC3, PSMD2, or PSMD12 siRNA knockdown. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (B) Western blotting of PSMC5, PSMC3, PSMD2, PSMD12, K48-ubiquitinated proteins, and cleaved caspase-3 levels, and quantification of K48-ubiquitinated proteins and cleaved caspase-3 in PSMC5, PSMC3, PSMD2, or PSMD12-knockdown cells. GAPDH served as protein loading control. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) In-gel proteasome chymotrypsin-like (CT-L) activity of the 30S, 26S, and 20S proteasome complexes and quantification thereof in PSMC5, PSMC3, PSMD2, or PSMD12-knockdown cells. The CT-L activity of proteasome complexes is visualized by their ability to cleave the Suc-LLVY-AMC fluorogenic peptide. The CT-L activity of the 30S, 26S, and 20S proteasome complexes of different knockdowns was normalized to the corresponding controls in the quantification plots. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (D) Immunoblotting of the native gel in (C) and probing of the membrane with anti-α1-7 antibody and quantification the amount of 30S, 26S, and 20S proteasome complexes indicated by α1-7. The protein level of α1-7 in the 30S, 26S, and 20S proteasome complexes of different knockdowns was normalized to the corresponding controls in the quantification plots. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; NS, not significant.
Figure 2 Knockdowns of the 19S RP subunits of the 26S proteasome impairs proteasome function and leads to apoptosis in HeLa cells. (A) LDH cytotoxicity assay to measure cell death caused by PSMC5, PSMC3, PSMD2, or PSMD12 siRNA knockdown. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (B) Western blotting of PSMC5, PSMC3, PSMD2, PSMD12, K48-ubiquitinated proteins, and cleaved caspase-3 levels, and quantification of K48-ubiquitinated proteins and cleaved caspase-3 in PSMC5, PSMC3, PSMD2, or PSMD12-knockdown cells. GAPDH served as protein loading control. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) In-gel proteasome chymotrypsin-like (CT-L) activity of the 30S, 26S, and 20S proteasome complexes and quantification thereof in PSMC5, PSMC3, PSMD2, or PSMD12-knockdown cells. The CT-L activity of proteasome complexes is visualized by their ability to cleave the Suc-LLVY-AMC fluorogenic peptide. The CT-L activity of the 30S, 26S, and 20S proteasome complexes of different knockdowns was normalized to the corresponding controls in the quantification plots. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (D) Immunoblotting of the native gel in (C) and probing of the membrane with anti-α1-7 antibody and quantification the amount of 30S, 26S, and 20S proteasome complexes indicated by α1-7. The protein level of α1-7 in the 30S, 26S, and 20S proteasome complexes of different knockdowns was normalized to the corresponding controls in the quantification plots. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; NS, not significant.CC BY · PubMed Central
Figure 3 Transient expression of PSMC5P320R in PSMC5-knockdown HeLa cells leads to the dissociation of the 19S RP from the 20S CP. (A) LDH cytotoxicity assay to compare cell death in PSMC5-knockdown HeLa cells transiently expressing Flag-PSMC5WT or PSMC5P320R. Cell death of control and PSMC5 knockdown groups was normalized to the corresponding vector groups, respectively. Plots represent mean ± SD (n = 5 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (B) Western blotting of PSMC5, K48-ubiquitinated proteins, and cleaved caspase-3 levels and quantification of K48-ubiquitinated proteins, and cleaved caspase-3 in PSMC5-knockdown HeLa cells transiently expressing Flag-PSMC5WT or PSMC5P320R. GAPDH served as protein loading control. The protein levels of K48-ubiquitinated proteins and cleaved caspase-3 were normalized to the corresponding vector groups in the quantification plots. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) Domain organization of PSMC5. (D) the structure of 26S proteasome and PSMC5 are shown as ribbon diagrams with PSMC5 highlighted in green and PSMC5P320 highlighted in red. The ribbon diagrams were generated using PyMOL software based on the solved structure of the human 26S proteasome (PDB 6MSH) [34]. (E) Immunoprecipitation of exogenously expressed Flag-PSMC5WT or PSMC5P320R in PSMC5-knockdown HeLa cells and quantification of the 19S RP and 20S CP subunits co-immunoprecipitated with Flag-PSMC5WT or PSMC5P320R. PSMC5 (LE) indicates a longer exposure of the PSMC5 blot. * in the blots indicates non-specific bands. The amount of all the preys (PSMC3, PSMD2, PSMD12, α1-7, and β5) co-immunoprecipitated with Flag-PSMC5 was normalized to the corresponding bait Flag-PSMC5 and then normalized to the corresponding Flag-PSMC5WT groups in the quantification plots. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. * indicates P < 0.05; ** indicates P < 0.01; NS, not significant. Endogenous PSMC5 is knocked down using PSMC5 siRNA oligo2 and exogenously expressed PSMC5WT or PSMC5P320R are PSMC5 siRNA oligo2-resistant.
Figure 3 Transient expression of PSMC5P320R in PSMC5-knockdown HeLa cells leads to the dissociation of the 19S RP from the 20S CP. (A) LDH cytotoxicity assay to compare cell death in PSMC5-knockdown HeLa cells transiently expressing Flag-PSMC5WT or PSMC5P320R. Cell death of control and PSMC5 knockdown groups was normalized to the corresponding vector groups, respectively. Plots represent mean ± SD (n = 5 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (B) Western blotting of PSMC5, K48-ubiquitinated proteins, and cleaved caspase-3 levels and quantification of K48-ubiquitinated proteins, and cleaved caspase-3 in PSMC5-knockdown HeLa cells transiently expressing Flag-PSMC5WT or PSMC5P320R. GAPDH served as protein loading control. The protein levels of K48-ubiquitinated proteins and cleaved caspase-3 were normalized to the corresponding vector groups in the quantification plots. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) Domain organization of PSMC5. (D) the structure of 26S proteasome and PSMC5 are shown as ribbon diagrams with PSMC5 highlighted in green and PSMC5P320 highlighted in red. The ribbon diagrams were generated using PyMOL software based on the solved structure of the human 26S proteasome (PDB 6MSH) [34]. (E) Immunoprecipitation of exogenously expressed Flag-PSMC5WT or PSMC5P320R in PSMC5-knockdown HeLa cells and quantification of the 19S RP and 20S CP subunits co-immunoprecipitated with Flag-PSMC5WT or PSMC5P320R. PSMC5 (LE) indicates a longer exposure of the PSMC5 blot. * in the blots indicates non-specific bands. The amount of all the preys (PSMC3, PSMD2, PSMD12, α1-7, and β5) co-immunoprecipitated with Flag-PSMC5 was normalized to the corresponding bait Flag-PSMC5 and then normalized to the corresponding Flag-PSMC5WT groups in the quantification plots. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. * indicates P < 0.05; ** indicates P < 0.01; NS, not significant. Endogenous PSMC5 is knocked down using PSMC5 siRNA oligo2 and exogenously expressed PSMC5WT or PSMC5P320R are PSMC5 siRNA oligo2-resistant.CC BY · PubMed Central
Figure 4 Engineered BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R show accumulation of K48-ubiquitinated proteins, apoptosis, and the dissociation of the 19S RP from the 20S CP. (A) CellTox green cytotoxicity assay to measure cell death of BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R. Plots represent mean ± SD (n = 6 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (B) Western blotting and quantification of PSMC5, K48-ubiquitinated proteins, and cleaved caspase-3 levels in BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R. GAPDH served as protein loading control. The average of two repeats shown in one western blot image was taken as a biological replicate. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R and wild-type control were transfected with Ub-G76V-GFP-IRES-DsRed, followed by FACS. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (D) Immunoprecipitation of PSMC3 in BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R and quantification of the 19S RP and 20S CP subunits co-immunoprecipitated with PSMC3. * in the blots indicates non-specific bands. The amount of all the preys (PSMC5, PSMD2, PSMD12, α1-7, and β5) co-immunoprecipitated with PSMC3 was normalized to the corresponding PSMC3 and then normalized to the corresponding +/+ groups in the quantification plots. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; NS, not significant. +/+: Wild type; P320R/+: Heterozygous PSMC5P320R; P320R/P320R: Homozygous PSMC5P320R. C13, clone 13; C26, clone 26; C28, clone 28; C102, clone 102.
Figure 4 Engineered BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R show accumulation of K48-ubiquitinated proteins, apoptosis, and the dissociation of the 19S RP from the 20S CP. (A) CellTox green cytotoxicity assay to measure cell death of BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R. Plots represent mean ± SD (n = 6 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (B) Western blotting and quantification of PSMC5, K48-ubiquitinated proteins, and cleaved caspase-3 levels in BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R. GAPDH served as protein loading control. The average of two repeats shown in one western blot image was taken as a biological replicate. Plots represent mean ± SD (n = 4 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R and wild-type control were transfected with Ub-G76V-GFP-IRES-DsRed, followed by FACS. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (D) Immunoprecipitation of PSMC3 in BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R and quantification of the 19S RP and 20S CP subunits co-immunoprecipitated with PSMC3. * in the blots indicates non-specific bands. The amount of all the preys (PSMC5, PSMD2, PSMD12, α1-7, and β5) co-immunoprecipitated with PSMC3 was normalized to the corresponding PSMC3 and then normalized to the corresponding +/+ groups in the quantification plots. Plots represent mean ± SD (n = 3 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; NS, not significant. +/+: Wild type; P320R/+: Heterozygous PSMC5P320R; P320R/P320R: Homozygous PSMC5P320R. C13, clone 13; C26, clone 26; C28, clone 28; C102, clone 102.CC BY · PubMed Central
Figure 5 Homozygous PSMC5P320R shows the decrease of 26S and 30S proteasome and the increase of 20S proteasome, and heterozygous PSMC5P320R shows the decrease of 30S proteasome and the increase of 20S proteasome. (A) Proteasome CT-L activity in BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R was assessed in gels using the Suc-LLVY-AMC fluorogenic peptide and quantification thereof. The CT-L activity of the 30S, 26S, and 20S proteasome complexes in different cell lines was normalized to the corresponding +/+ groups in the quantification plots. Plots represent mean ± SD (n = 6 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (B) Immunoblotting of the native gel in (A) and probing of the membrane with anti-α1-7 antibody and quantification the amount of 30S, 26S, and 20S proteasome complexes or the ratio of 30S/20S and 26S/20S indicated by α1-7. The protein level of α1-7 in the 30S, 26S, and 20S proteasome complexes or in the ratio of 30S/20S and 26S/20S in different cell lines was normalized to the corresponding +/+ groups in the quantification plots. Plots represent mean ± SD (n = 7 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) Immunoblotting of the native gel in (A) and probing of the membrane with anti-PSMC3 antibody and quantification the amount of 30S and 26S proteasome complexes indicated by PSMC3. The protein level of PSMC3 in the 30S, 26S, and 20S proteasome complexes in different cell lines was normalized to the corresponding +/+ groups in the quantification plots. Plots represent mean ± SD (n = 7 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; NS, not significant. +/+: Wild type; P320R/+: Heterozygous PSMC5P320R; P320R/P320R: Homozygous PSMC5P320R. C13, clone 13; C26, clone 26; C28, clone 28; C102, clone 102.
Figure 5 Homozygous PSMC5P320R shows the decrease of 26S and 30S proteasome and the increase of 20S proteasome, and heterozygous PSMC5P320R shows the decrease of 30S proteasome and the increase of 20S proteasome. (A) Proteasome CT-L activity in BE(2)-M17 cells carrying homozygous or heterozygous PSMC5P320R was assessed in gels using the Suc-LLVY-AMC fluorogenic peptide and quantification thereof. The CT-L activity of the 30S, 26S, and 20S proteasome complexes in different cell lines was normalized to the corresponding +/+ groups in the quantification plots. Plots represent mean ± SD (n = 6 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (B) Immunoblotting of the native gel in (A) and probing of the membrane with anti-α1-7 antibody and quantification the amount of 30S, 26S, and 20S proteasome complexes or the ratio of 30S/20S and 26S/20S indicated by α1-7. The protein level of α1-7 in the 30S, 26S, and 20S proteasome complexes or in the ratio of 30S/20S and 26S/20S in different cell lines was normalized to the corresponding +/+ groups in the quantification plots. Plots represent mean ± SD (n = 7 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. (C) Immunoblotting of the native gel in (A) and probing of the membrane with anti-PSMC3 antibody and quantification the amount of 30S and 26S proteasome complexes indicated by PSMC3. The protein level of PSMC3 in the 30S, 26S, and 20S proteasome complexes in different cell lines was normalized to the corresponding +/+ groups in the quantification plots. Plots represent mean ± SD (n = 7 independent experiments). P values were calculated using two-tailed, paired Student’s t-test. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; NS, not significant. +/+: Wild type; P320R/+: Heterozygous PSMC5P320R; P320R/P320R: Homozygous PSMC5P320R. C13, clone 13; C26, clone 26; C28, clone 28; C102, clone 102.CC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 1 Not valid · 2 Not checked · 62 Own results and interpretations

43 more claims

Create a free account to see all 73 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 15
  • Probably not a substantial claim. 9
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 41 references

Cited by

See all 4

Metadata

Authors
Yu, Z.-Q., Carmichael, J., Collins, G. A., D'Agostino, M. D., Lessard, M., Firth, H. V., Harijan, P., Fry, A. E., Dean, J., Zhang, J., Kini, U., Goldberg, A. L., & Rubinsztein, D. C.
Affiliations
  • University of Cambridge (GB)
  • Cambridge University Hospitals NHS Foundation Trust (GB)
  • Harvard University (US)
  • Division of Medical Genetics , Department of Specialised Medicine, , 1001 Decarie Boulevard, Montreal, Quebec, H4A 3J1 , Canada
  • Children's Hospital of Eastern Ontario (CA)
  • Addenbrooke's Hospital (GB)
  • University Hospital of Wales (GB)
  • University of Aberdeen (GB)
  • University of Oxford (GB)
Corresponding author
Rubinsztein, David C
Venue
Human Molecular Genetics
Published
2024-05-22
Volume
33
Issue
17
Pages
1506-1523
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W4398193136
Cited by
4
References
42
Citations by year
2026: 1 · 2025: 3
FWCI
0.54
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • Cure Alzheimer's Fund
  • Wellcome Trust (WT 098051, 098051)
  • Alzheimer's Society
  • National Institute for Health and Care Research ((NIHR203312, HICF-1009-003)
  • Department of Health and Social Care
  • Rosetrees Trust
  • UK Dementia Research Institute
  • National Institutes of Health
  • Medical Research Council (NIHR203312)
  • NIHR Cambridge Biomedical Research Centre (NIHR 203312)
  • National Institute of General Medical Sciences (R01GM051923)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
proteasome dysfunction, 19S regulatory particle, AAA+ ATPase, neurodevelopmental disorders, variants of uncertain significance, ubiquitin-proteasome system, apoptosis, 20S core particle, proteasome assembly, neurodegenerative diseases
MeSH terms
Female, Humans, Male, Mutation, Apoptosis, Ubiquitin, Proteasome Endopeptidase Complex, HEK293 Cells, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PSMC5 insufficiency and P320R mutation impair proteasome function. https://app.cochat.ai/papers/10.1093/hmg/ddae085
The paper
Yu, Z.-Q., Carmichael, J., Collins, G. A., D'Agostino, M. D., Lessard, M., Firth, H. V., Harijan, P., Fry, A. E., Dean, J., Zhang, J., Kini, U., Goldberg, A. L., & Rubinsztein, D. C. (2024). PSMC5 insufficiency and P320R mutation impair proteasome function. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae085

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.